References

• Spencer TJ, Biederman J, Mick E. Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology. J Pediatr Psychol 2007; 32(6): 631–42. [CrossRef]
   PubMed Web of Science ®Google Scholar
• Stahl SM. Neurotransmission of cognition, part 3. Mechanism of action of selective NRIs: both dopamine and norepinephrine increase in prefrontal cortex. J Clin Psychiatry 2003; 64(3): 230–1. [CrossRef]
   PubMed Web of Science ®Google Scholar
• Zoroglu SS, Herken H, Yurekli M, Uz E, Tutkun H, Savas HA, et al. The possible pathophysiological role of plasma nitric oxide and adrenomedullin in schizophrenia. J Psych Research 2002; 36(5): 309–15. [CrossRef]
   Google Scholar
• Pasca SP, Nemes B, Vlase L, Gagyi CE, Dronca E, Miu AC, et al. High levels of homocysteine and low serum paraoxonase larylesterase activity in children with autism. Life Sci 2006; 78(19): 2244–8. [CrossRef]
   Web of Science ®Google Scholar
• Ceylan MF, Sener S, Bayraktar AC, Kavutcu M. Changes in oxidative stress and cellular immunity serum markers in attention-deficit/hyperactivity disorder. Psychiatry Clin Neurosci 2012; 66(Suppl. 3): 220–6. [CrossRef]
   Web of Science ®Google Scholar
• Selek S, Bulut M, Ocak AR, Kalenderoglu A, Savas HA. Evaluation of total oxidative status in adult attention deficit hyperactivity disorder and its diagnostic implications. J Psychiatr Res 2012; 46(Suppl.4): q451–5. [CrossRef]
   Web of Science ®Google Scholar
• Machado-Vieira R, Andreazza AC, Viale CI, Zanatto V, Cereser V, Silva Vargas R, et al. Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects. Neurosci Lett 2007; 421(1): 33–6. [CrossRef]
   PubMed Web of Science ®Google Scholar
• Mahadik SP, Mukherjee S. Free radical pathology and antioxidant defense in schizophrenia: a review. Schizophrenia Res 1996; 19(1–2): 1–17. [CrossRef]
   Web of Science ®Google Scholar
• Reddy RD, Yao JK. Free radical pathology in schizophrenia: a review. Prostaglandins Leukot Essent Fatty Acids 1996; 55(1): 33–43. [CrossRef]
   Web of Science ®Google Scholar
• Yorbik O, Cansever A, Sohmen T. Neuronal Aspects In Autism. Turkish Journal of Child and Adolescent Mental Health 2002; 9: 118–27. (Turkish)
   Google Scholar
• Halliwell B, Gutteridge JMG, Cross CE. Free Radicals antioxidants and human disease: Where are we now? Lab Clin Med 1992; 119(6): 598–620.
   PubMed Web of Science ®Google Scholar
• Memisogullari R, Bakan E. Levels of ceruloplasmin, transferrin, and lipid peroxidation in the serum of patients with Type 2 diabetes mellitus. Journal of Diabetes and Its Complications 2004; 18(4): 193–7. [CrossRef]
   Web of Science ®Google Scholar
• Vassiliev V, Harris ZL, Zatta P. Ceruloplasmin in neurodegenerative diseases. Brain Res Brain Res Rev 2005; 49(3): 633–40. [CrossRef]
   Google Scholar
• Akil M, Brewer GJ. Psychiatric and behavioral abnormalities in Wilson's disease. Adv Neurol 1995; 65: 171–8.
   PubMedGoogle Scholar
• McDonald LV, Lake CR. Psychosis in an adolescent patient with Wilson's disease: effects of chelation therapy. Psychosom Med 1995; 57(2): 202–4. [CrossRef]
   Web of Science ®Google Scholar
• Goral V. Wilson Disease: 2010. Güncel Gastroenteroloji 2010; 14(2): 66–75. (Turkish)
   Google Scholar
• Silva F, Nobre S, Campos AP, Vasconcelos M, Gonçalves I. Behavioural and psychiatric disorders in pediatric Wilson's disease. BMJ Case Rep Aug 4; 2011. pii: bcr0520114249. doi:10.1136/bcr.05.2011.4249. [CrossRef]
   Google Scholar
• Wolf TL, Kotun J, Meador-Woodruff JH. Plasma copper, iron, ceruloplasmin and ferroxidase activity in schizophrenia. Schizophr Res 2006; 86(1–3): 167–71. [CrossRef]
   Web of Science ®Google Scholar
• Virit O, Altindag A, Selek S, Yumru M, Bulut M, Erel O, et al. Increased Plasma Ceruloplasmin Levels in Schizophrenia. Klinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacology 2008; 18: 282–7.
   Google Scholar
• Yanik M, Kocyigit A, Tutkun H, Vural H, Herken H. Plasma manganese, selenium, zinc, copper, and iron concentrations in patients with schizophrenia. Biol Trace Elem Res 2004; 98(2): 109–18. [CrossRef]
   Web of Science ®Google Scholar
• Gillin JC, Carpenter WT, Hambidge KM, Wyatt RJ, Henkin RI. Zinc and copper in patients with schizophrenia. Encephale 1982; 8(3): 435–44.
   Google Scholar
• Jackson MJ, Garrod PJ. Plasma zinc, copper, and amino acid levels in the blood of autistic children. J Autism Child Schizophr 1978; 8(2): 203–8. [CrossRef]
   Google Scholar
• Blaurock-Busch E, Amin OR, Rabah T. Heavy metals and trace elements in hair and urine of a sample of arab children with autistic spectrum disorder. Maedica (Buchar) 2011; 6(4): 247–57.
   Google Scholar
• Sutton AL, Brumm MC, Kelly DT, Henderson CA, Mayrose VB. Effect of dietary salt, arsenic and copper additions and waste management systems on selected microbial organisms in swine wastes. J Anim Sci 1980; 51(4): 791–7.
   Web of Science ®Google Scholar
• Wecker L, Miller SB, Cochran SR ve ark. Trace element concentrations in hair from autistic children. J Ment Defic Res 1985; 29(1): 15–22.
   Google Scholar
• Atasoy A. Early Childhood Autism and Trace Elements in Hair. Postgraduate thesis. Gazi University Faculty of Medicine, Ankara. 1986 (Turkish)
   Google Scholar
• Chauhan A, Chauhan V, Brown WT, Cohen I. Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin—the antioxidant proteins. Life Sci 2004; 75(21): 2539–49.
   PubMed Web of Science ®Google Scholar
• Parellada M, Moreno C, Mac-Dowell K, Leza JC, Giraldez M, Balion C, at al. Plasma antioxidant capacity is reduced in Asperger syndrome. J Psychiatr Res 2012; 46(3): 394–401. [CrossRef]
   Web of Science ®Google Scholar
• Archana E, Pai P, Prabhu BK, Shenoy RP, Prabhu K, Rao A. Altered biochemical parameters in saliva of pediatric attention deficit hyperactivity disorder. Neurochem Res 2012; 37(2): 330–4. [CrossRef]
   Web of Science ®Google Scholar
• Mahmoud MM, El-Mazary AA, Maher R, Saber MM. Zinc, ferritin, magnesium and copper in a group of Egyptian children with attention deficit hyperactivity disorder. Ital J Pediatr 2011; 37:60. [CrossRef]
   PubMed Web of Science ®Google Scholar
• Yorbik O, Olgun A, Kirmizigul P, Akman S. Plasma Zinc and Copper Levels in Boys with Oppositional Defiant Disorder. Turkish Journal of Pscyhiatry 2004; 15(4): 276–281. (Turkish)
   Google Scholar
• Kozilec T, Starobrat-Hermelin B, Kotkowiak L. Deficiency of certain trace elements in children with hyperactivity. Psychiatr Pol 1994; 28(3): 345–53.
   Google Scholar
• Bekaroglu M, Arslan Y, Deger O, Gedik Y, Karahan SC, Soylu C. Plasma Zinc and Copper Levels in school children with Attention Deficit Hyperactivity Disorder. Düşünen Adam The Journal of Psychiatry and Neurological Sciences 1993; 6(3): 7–9. (Turkish)
   Google Scholar
• Starobrat-Hermelin B. The effect of deficiency of selected bioelements on hyperactivity in children with certain specified mental disorders. Ann Acad Med Stetin 1998; 44: 297–314.
   PubMedGoogle Scholar
• Yorbik O, Olgun A, Kirmizigul P, Akman S. Plasma Zinc and Copper Levels in Boys with Attention Deficit Hyperactivity Disorder. Klinik Psikiyatri 2004; 7: 80–4. (Turkish)
   Google Scholar